Literature DB >> 21177807

Foot-and-mouth disease virus exhibits an altered tropism in the presence of specific immunoglobulins, enabling productive infection and killing of dendritic cells.

L Robinson1, M Windsor, K McLaughlin, J Hope, T Jackson, B Charleston.   

Abstract

Foot-and-mouth disease virus (FMDV) causes an acute vesicular disease of farm animals. The development of successful control strategies is limited by an incomplete understanding of the immune response to FMDV. Dendritic cells (DC) mediate the induction of immunity to pathogens, but their role in FMDV infection of cattle is uncharacterized. Bovine monocyte-derived DC (moDC) were exposed to integrin-binding and cell culture-adapted strains of FMDV in vitro. MoDC were not largely susceptible to infection by integrin-binding FMDV but were susceptible to culture-adapted virus. Binding specific antibodies to integrin-binding FMDV at neutralizing or subneutralizing IgG concentrations significantly enhanced infection via CD32 (FcγR). Monocytes also expressed CD32 but were nonsusceptible to FMDV immune complex (IC) infection, indicating a requirement for additional factors involved in cellular susceptibility. Infection of moDC by the FMDV IC was productive and associated with high levels of cell death. Infected moDC were unable to efficiently stimulate FMDV-specific CD4(+) memory T cells, but exposing moDC to IC containing inactivated FMDV resulted in significantly increased T cell stimulation. Thus, neutralized FMDV concurrently loses its ability to infect susceptible cells while gaining the capacity to infect immune cells. This represents a change in the tropism of FMDV that could occur after the onset of the antibody response. We propose that IC could dynamically influence the anti-FMDV immune response and that this may explain why the early immune response to FMDV has evolved toward T cell independence in vivo. Moreover, we propose that DC targeting could prove useful in the development of effective vaccines against FMDV.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21177807      PMCID: PMC3067760          DOI: 10.1128/JVI.02180-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  61 in total

Review 1.  Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications.

Authors:  Ayato Takada; Yoshihiro Kawaoka
Journal:  Rev Med Virol       Date:  2003 Nov-Dec       Impact factor: 6.989

2.  Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection.

Authors:  R Littaua; I Kurane; F A Ennis
Journal:  J Immunol       Date:  1990-04-15       Impact factor: 5.422

3.  Opsonization-enhanced phagocytosis of foot-and-mouth disease virus.

Authors:  K C McCullough; D Parkinson; J R Crowther
Journal:  Immunology       Date:  1988-10       Impact factor: 7.397

4.  T cell-dependent induction of antibody against foot-and-mouth disease virus in a mouse model.

Authors:  T Collen; L Pullen; T R Doel
Journal:  J Gen Virol       Date:  1989-02       Impact factor: 3.891

5.  RGD sequence of foot-and-mouth disease virus is essential for infecting cells via the natural receptor but can be bypassed by an antibody-dependent enhancement pathway.

Authors:  P W Mason; E Rieder; B Baxt
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-01       Impact factor: 11.205

6.  Antibody-complexed foot-and-mouth disease virus, but not poliovirus, can infect normally insusceptible cells via the Fc receptor.

Authors:  P W Mason; B Baxt; F Brown; J Harber; A Murdin; E Wimmer
Journal:  Virology       Date:  1993-02       Impact factor: 3.616

7.  Immune response to foot-and-mouth disease virus in a murine experimental model: effective thymus-independent primary and secondary reaction.

Authors:  M V Borca; F M Fernández; A M Sadir; M Braun; A A Schudel
Journal:  Immunology       Date:  1986-10       Impact factor: 7.397

8.  Quantitative analysis of foot-and-mouth disease virus RNA loads in bovine tissues: implications for the site of viral persistence.

Authors:  Zhidong Zhang; Soren Alexandersen
Journal:  J Gen Virol       Date:  2004-09       Impact factor: 3.891

9.  Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization.

Authors:  A Regnault; D Lankar; V Lacabanne; A Rodriguez; C Théry; M Rescigno; T Saito; S Verbeek; C Bonnerot; P Ricciardi-Castagnoli; S Amigorena
Journal:  J Exp Med       Date:  1999-01-18       Impact factor: 14.307

10.  Integrin alphavbeta8 functions as a receptor for foot-and-mouth disease virus: role of the beta-chain cytodomain in integrin-mediated infection.

Authors:  Terry Jackson; Stuart Clark; Stephen Berryman; Alison Burman; Stephanie Cambier; Dezhi Mu; Stephen Nishimura; Andrew M Q King
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

View more
  12 in total

Review 1.  Viral quasispecies evolution.

Authors:  Esteban Domingo; Julie Sheldon; Celia Perales
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

2.  Foot-and-mouth disease virus induces autophagosomes during cell entry via a class III phosphatidylinositol 3-kinase-independent pathway.

Authors:  Stephen Berryman; Elizabeth Brooks; Alison Burman; Philippa Hawes; Rebecca Roberts; Christopher Netherton; Paul Monaghan; Matthew Whelband; Eleanor Cottam; Zvulun Elazar; Terry Jackson; Thomas Wileman
Journal:  J Virol       Date:  2012-09-19       Impact factor: 5.103

3.  Characterization of epitope-tagged foot-and-mouth disease virus.

Authors:  Julian Seago; Terry Jackson; Claudia Doel; Elizabeth Fry; David Stuart; Michiel M Harmsen; Bryan Charleston; Nicholas Juleff
Journal:  J Gen Virol       Date:  2012-07-18       Impact factor: 3.891

4.  Cattle remain immunocompetent during the acute phase of foot-and-mouth disease virus infection.

Authors:  Miriam A Windsor; B Veronica Carr; Bartomiej Bankowski; Debi Gibson; Elizabeth Reid; Pip Hamblin; Simon Gubbins; Nicholas Juleff; Bryan Charleston
Journal:  Vet Res       Date:  2011-10-20       Impact factor: 3.683

5.  Early events in the pathogenesis of foot-and-mouth disease in pigs; identification of oropharyngeal tonsils as sites of primary and sustained viral replication.

Authors:  Carolina Stenfeldt; Juan M Pacheco; Luis L Rodriguez; Jonathan Arzt
Journal:  PLoS One       Date:  2014-09-03       Impact factor: 3.240

Review 6.  Foot-and-Mouth Disease Virus: Immunobiology, Advances in Vaccines and Vaccination Strategies Addressing Vaccine Failures-An Indian Perspective.

Authors:  Raj Kumar Singh; Gaurav Kumar Sharma; Sonalika Mahajan; Kuldeep Dhama; Suresh H Basagoudanavar; Madhusudan Hosamani; B P Sreenivasa; Wanpen Chaicumpa; Vivek Kumar Gupta; Aniket Sanyal
Journal:  Vaccines (Basel)       Date:  2019-08-16

Review 7.  Laboratory animal models to study foot-and-mouth disease: a review with emphasis on natural and vaccine-induced immunity.

Authors:  Mohammed Habiela; Julian Seago; Eva Perez-Martin; Ryan Waters; Miriam Windsor; Francisco J Salguero; James Wood; Bryan Charleston; Nicholas Juleff
Journal:  J Gen Virol       Date:  2014-07-07       Impact factor: 3.891

8.  Macrophage Polarization in Virus-Host Interactions.

Authors:  Yongming Sang; Laura C Miller; Frank Blecha
Journal:  J Clin Cell Immunol       Date:  2015-04

9.  Induction of partial protection against foot and mouth disease virus in guinea pigs by neutralization with the integrin β6-1 subunit.

Authors:  Yan Zhang; Yingjun Sun; Fan Yang; Jianhong Guo; Jijun He; Qiong Wu; Weijun Cao; Lv Lv; Haixue Zheng; Zhidong Zhang
Journal:  Viruses       Date:  2013-04-19       Impact factor: 5.048

10.  RNAi combining Sleeping Beauty transposon system inhibits ex vivo expression of foot-and-mouth disease virus VP1 in transgenic sheep cells.

Authors:  Shoulong Deng; Guangdong Li; Kun Yu; Xiuzhi Tian; Feng Wang; Wenting Li; Wuqi Jiang; Pengyun Ji; Hongbing Han; Juncai Fu; Xiaosheng Zhang; Jinlong Zhang; Yixun Liu; Zhengxing Lian; Guoshi Liu
Journal:  Sci Rep       Date:  2017-08-30       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.